课题基金 / 基金详情

项目摘要

项目成果

MICHAEL J FRANKLIN的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):铜绿假单胞菌是一种条件致病菌,在囊性纤维化患者的肺组织上形成生物膜,导致慢性感染。对来自单个CF患者的铜绿假单胞菌分离株的纵向基因组学研究表明,随着时间的推移,这些细菌株往往是克隆的。这表明,最初的创始菌株的亚群在抗生素治疗后存活下来,然后在治疗缓解时重新填充生物膜。幸存的细菌被称为持久细胞。持久细胞可能在代谢上处于休眠状态,部分原因是生物膜含有氧气或养分利用率较低的微环境。为了消除慢性感染,要么防止持久细胞的形成,要么防止它们从休眠中复苏。在这里,我们将重点放在后一种方法上,通过表征允许细菌在休眠条件下长时间存活的因素的作用。利用激光捕获显微切割(LCM)和转录组学技术,我们鉴定了在铜绿假单胞菌生物膜的休眠、耐药亚群中丰富的mRNA转录本。这些转录本编码核糖体冬眠因子HPF和RMF,已在大肠杆菌中显示出将活性核糖体转换为静止的100S二聚体。由于许多抗生素以翻译为目标,核糖体失活的细菌将对这些抗生素产生耐受性。此外,我们的初步研究表明,在非生长条件下,铜绿假单胞菌中缺乏这些因素会导致细胞活力的丧失。HPF的缺失导致50S核糖体亚基的23S rRNA几乎完全降解。由于现成的核糖体是细胞从休眠中恢复所必需的,这些因子可能是为了保护核糖体在饥饿条件下不完全降解而进化的。因此,本研究的目的是进一步确定这些核糖体冬眠因子的表达和活性,并确定它们在铜绿假单胞菌生物膜细胞从休眠状态中恢复的作用。在这项研究中,我们将:(I)鉴定RMF和HPF的分子活性,并确定它们在铜绿假单胞菌休眠生物膜亚群核糖体丰度和生存中的作用;(Ii)鉴定RMF和HPF的转录调控,以确定TIR在生物膜中高表达所需的因素;以及(Iii)确定mRNA折叠和其他转录后调控过程在这些因子在生物膜中表达的作用。最终,我们 将确定允许生物膜细胞从休眠中恢复的分子机制。然后,这些机制可能被用作杀死引起慢性铜绿假单胞菌肺部感染的休眠生物被膜细菌的靶标。
英文摘要
DESCRIPTION (provided by applicant): Pseudomonas aeruginosa is an opportunistic pathogen that forms biofilms on the pulmonary tissue of patients with cystic fibrosis (CF), resulting in chronic infections. Longitudinal genomics studies of P. aeruginosa isolates from individual CF patients indicate that the bacterial strains are often clonal over time. This suggest that subpopulations of the original founder strains survive the antibiotic treatments, then repopulate the biofilms when treatments are alleviated. The surviving bacteria are termed persister cells. Persister cells may be metabolically dormant, and arise in part because biofilms contain microenvironments with low oxygen or nutrient availability. In order to eliminate chronic infections, it will be necessary to either prevent the formation of persister cells or prevent thei resuscitation from dormancy. Here, we will focus on the latter approach, by characterizing the role of factors that allow prolonged survival of bacteria under dormant conditions. Using laser capture microdissection (LCM) and transcriptomics, we identified mRNA transcripts that are abundant in the dormant, antibiotic-tolerant subpopulations of P. aeruginosa biofilms. These transcripts code for ribosome hibernation factors, HPF and RMF, which have been shown in Escherichia coli to convert active ribosomes to resting 100S dimers. Since many antibiotics target translation, bacteria with inactivated ribosomes would be tolerant to these antibiotics. In addition, our preliminary studies demonstrate that the absence of these factors in P. aeruginosa results in loss of cell viability during non- growth conditions. Loss of HPF results in almost complete degradation of the 23S rRNA of the 50S ribosomal subunit. Since ready-made ribosomes are necessary for cell recovery from dormancy, these factors likely evolved to protect ribosomes from complete degradation during starvation conditions. Therefore, the goals of this research are to characterize further the expression and activity of these ribosome hibernation factors and determine their role in recovery of P. aeruginosa biofilm cells from dormancy. In this research we will: (i) characterize the molecular activities of RMF and HPF, and determine their role in ribosome abundances and survival of the P. aeruginosa dormant biofilm subpopulations, (ii) characterize the transcriptional regulation of rmf and hpf, to identify factors required for teir high expression in biofilms, and (iii) determine the role of mRNA folding and other post-transcriptional regulatory processes in the expression of these factors in biofilms. Ultimately, we will identify molecular mechanisms that allow recovery of biofilm cells from dormancy. These mechanisms may then be used as targets to kill the dormant biofilm bacteria that cause chronic P. aeruginosa pulmonary infections.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of Ribosome Hibernation in the Tolerance of P. aeruginosa Biofilms to Antibiotics
Role of Ribosome Hibernation in the Tolerance of P. aeruginosa Biofilms to Antibiotics
Resuscitation of P. aeruginosa biofilm cells from dormancy
Role of IbpA in maintaining viability of P. aeruginosa biofilm persister cells
海外基金